Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Food as medicine: tailored meals may help heart failure patients eat better

NCT ID NCT06540118

Disease control Sponsor: University of California, San Diego Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether providing medically tailored meals to people with heart failure could improve their diet quality. Sixty participants received heart-healthy meals delivered to their homes for 12 weeks. The main goal was to see if their diet scores improved by the end of the study.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
medically tailored meals
What this could lead to
If it works, this could show that providing healthy meals helps people with heart failure eat better and possibly manage their condition.
What could go wrong
This is a small, completed study with only 60 participants. It measures diet quality, not heart failure outcomes, so benefits for the disease itself are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Oct 2024

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Willingness to comply with all study procedures and availability for the duration of the study * Living in San Diego or the Bay Area of California * Reported congestive heart failure (CHF) diagnosis * Current diet can be improved * Willing to eat all meals provided by the study Exclusion Criteria: * Diagnosed with end-stage heart failure * Diagnosed with diabetes (type 1 or uncontrolled type 2) * Currently taking insulin and/or meglitinides medications * Currently taking Glucagon-Like Peptide-1 (GLP-1) Agonists medications and not stable on a maximum maintenance dose for a minimum of 1 month * Hemoglobin A1c (HbA1c) results \>8 % * Life expectancy of \<1 year * Pregnancy or lactation * Known severe allergic reactions and/or food intolerances that would interfere with the ability to eat study-provided meals, including foods that are prepared in a facility that works with the allergen * Current smoker or tobacco use within the past year * Planning to leave San Diego or the Bay Area during the course of the study * Unable to communicate reasonably well either orally or through written material in English * Those who, in the opinion of the investigators, cannot reliably complete the study protocol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Heart diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

congestive heart failure heart disorder heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Heart diseases Heart failure Heart failure, congestive

Contacts and locations

Locations

  • Stanford University

    Stanford, California, 94305, United States

  • University of California San Diego

    La Jolla, California, 92093, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.